Evidence map›Paper›PMID 36879062›Full record

ArticleNature chemical biology2023

Author Correction: Structural basis of efficacy-driven ligand selectivity at GPCRs.

Alexander S Powers, Vi Pham, Wessel A C Burger, Geoff Thompson, Yianni Laloudakis, Nicholas W Barnes, Patrick M Sexton, Steven M Paul, Arthur Christopoulos, David M Thal and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Alexander S PowersDepartment of Chemistry, Stanford University, Stanford, CA, USA.
Vi PhamDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Wessel A C BurgerDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0003-2047-2593
Geoff ThompsonDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Yianni LaloudakisDepartment of Computer Science, Stanford University, Stanford, CA, USA.
Nicholas W BarnesDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Patrick M SextonDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0001-8902-2473
Steven M PaulKaruna Therapeutics, Boston, MA, USA.
Arthur ChristopoulosDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0003-4442-3294
David M ThalDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0002-0325-2524
Christian C FelderKaruna Therapeutics, Boston, MA, USA.
Celine ValantDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. celine.valant@monash.edu.ORCID http://orcid.org/0000-0002-2509-7465
Ron O DrorDepartment of Computer Science, Stanford University, Stanford, CA, USA. ron.dror@stanford.edu.ORCID http://orcid.org/0000-0002-6418-2793

Funding

National Science Foundation (NSF) Graduate Research Fellowship
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36879062
PMCPMC10060150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.